Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-17

Clinical Trial Update: Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing caspofungin to fluconazole for preventing invasive fungal infections in patients undergoing chemotherapy for acute myeloid leukemia; stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Caspofungin (caspofungin)
  • Fluconazole (Fluconazole)

Snippet

Sponsor: Children's Oncology Group | Conditions: Acute Myeloid Leukemia, Adult Acute Monoblastic Leukemia | Phase 3 | Status: COMPLETED | Results posted: 2019-09-17